Manuel Ritter Selected Research

Renal Cell Carcinoma (Grawitz Tumor)

4/2024	High serum sodium predicts immunotherapy response in metastatic renal cell and urothelial carcinoma.
1/2024	Ring Finger Protein 34 (RNF34) as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.
1/2024	Hypermethylated SHOX2 in circulating cell-free DNA post renal cell carcinoma surgery as TNM-independent biomarker for recurrence risk.
1/2023	Integrating On-Treatment Modified Glasgow Prognostic Score and Imaging to Predict Response and Outcomes in Metastatic Renal Cell Carcinoma.
1/2023	Depletion of the m6A demethylases FTO and ALKBH5 impairs growth and metastatic capacity through EMT phenotype change in clear cell renal cell carcinoma.
3/2022	CD103+ Tissue Resident T-Lymphocytes Accumulate in Lung Metastases and Are Correlated with Poor Prognosis in ccRCC.
1/2022	RNA Sequencing Reveals Alterations and Similarities in Cell Metabolism, Hypoxia and Immune Evasion in Primary Cell Cultures of Clear Cell Renal Cell Carcinoma.
11/2021	Systematic expression analysis of m6A RNA methyltransferases in clear cell renal cell carcinoma.
9/2021	Comprehensive Analysis of the ATP-binding Cassette Subfamily B Across Renal Cancers Identifies ABCB8 Overexpression in Phenotypically Aggressive Clear Cell Renal Cell Carcinoma.
4/2021	CircEHD2, CircNETO2 and CircEGLN3 as Diagnostic and Prognostic Biomarkers for Patients with Renal Cell Carcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manuel Ritter Research Topics

Disease

37	Neoplasms (Cancer) 04/2024 - 01/2018
19	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 01/2020
18	Infections 04/2023 - 01/2013
15	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 11/2017
10	Neoplasm Metastasis (Metastasis) 05/2024 - 01/2018
10	Carcinoma (Carcinomatosis) 04/2024 - 12/2018
5	Inflammation (Inflammations) 01/2022 - 01/2013
4	Carcinogenesis 01/2024 - 01/2021
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 01/2018
3	Intestinal Volvulus (Volvulus) 01/2023 - 10/2020
3	Onchocerciasis 01/2022 - 01/2021
3	Kidney Neoplasms (Kidney Cancer) 09/2021 - 09/2020
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 04/2024 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2022
2	Elephantiasis 01/2023 - 07/2021
2	Pain (Aches) 09/2022 - 08/2012
2	Schistosomiasis mansoni 12/2021 - 11/2010
2	Filarial Elephantiasis (Lymphatic Filariasis) 12/2021 - 01/2019
2	Loiasis 11/2021 - 02/2020
2	Oxyphilic Adenoma (Oncocytoma) 11/2021 - 01/2020
2	Mansonelliasis 01/2019 - 01/2016
1	Lung Neoplasms (Lung Cancer) 01/2024
1	Communicable Diseases (Infectious Diseases) 03/2023
1	HIV Infections (HIV Infection) 02/2023
1	Noncommunicable Diseases 01/2023
1	Epilepsy (Aura) 01/2023
1	Insulin Resistance 01/2023
1	Metabolic Diseases (Metabolic Disease) 01/2023
1	Obesity 01/2023
1	Parasitic Diseases (Parasitic Disease) 01/2023
1	Overweight 01/2023
1	Nodding Syndrome 01/2023

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2020
15	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2020
14	Messenger RNA (mRNA)IBA 01/2024 - 12/2018
10	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2020
6	C-Reactive ProteinIBA 11/2023 - 01/2017
6	Ivermectin (Mectizan)FDA Link 12/2021 - 01/2016
5	AntigensIBA 03/2024 - 02/2020
5	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2021
5	CytokinesIBA 01/2023 - 12/2014
4	Immunoglobulin G (IgG)IBA 01/2023 - 01/2016
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
3	AlbuminsIBA 11/2023 - 01/2023
3	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 02/2020
2	Hemoglobins (Hemoglobin)IBA 05/2024 - 01/2017
2	enfortumab vedotinIBA 04/2024 - 01/2023
2	Immunoconjugates (Immunoconjugate)IBA 04/2024 - 01/2023
2	Hormones (Hormone)IBA 04/2023 - 09/2022
2	ChemokinesIBA 01/2023 - 02/2020
2	atezolizumabIBA 01/2023 - 01/2023
2	ClayIBA 01/2023 - 07/2021
2	AnthelminticsIBA 01/2023 - 07/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2020
2	6-methyladenineIBA 01/2023 - 11/2021
2	MethyltransferasesIBA 01/2023 - 11/2021
2	AndrogensIBA 09/2022 - 11/2020
2	N-acetyltalosaminuronic acid (NAT)IBA 09/2022 - 01/2020
2	Albendazole (Albenza)FDA Link 12/2021 - 01/2019
2	Tumor Biomarkers (Tumor Markers)IBA 04/2021 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 01/2019 - 01/2017
2	OvalbuminIBA 12/2014 - 01/2013
1	SodiumIBA 04/2024
1	EnzymesIBA 02/2024
1	ImmunosorbentsIBA 02/2024
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 02/2024
1	Circulating Tumor DNAIBA 01/2024
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2024
1	erdafitinibIBA 01/2024
1	pertuzumabIBA 01/2024
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2024
1	Cell-Free Nucleic AcidsIBA 01/2024
1	Phenobarbital (Luminal)FDA Link 04/2023
1	ChitinasesIBA 02/2023
1	Docetaxel (Taxotere)FDA Link 01/2023
1	Decitabine FDA Link 01/2023
1	Blood Glucose (Blood Sugar)IBA 01/2023
1	Cytotoxins (Cytolysins)IBA 01/2023
1	InterferonsIBA 01/2023
1	Irritants (Vesicants)IBA 01/2023
1	LipidsIBA 01/2023
1	AdipokinesIBA 01/2023
1	B7-H1 AntigenIBA 01/2023
1	Androgen Receptors (Androgen Receptor)IBA 09/2022
1	Cisplatin (Platino)FDA LinkGeneric 06/2022

Therapy/Procedure

15	Therapeutics 01/2024 - 01/2018
6	Prostatectomy (Retropubic Prostatectomy) 02/2024 - 01/2017
5	Immunotherapy 04/2024 - 01/2021
5	Mass Drug Administration 04/2023 - 01/2019
3	Immunomodulation 03/2023 - 01/2021
3	Length of Stay 01/2020 - 11/2017
3	Cystectomy 03/2019 - 01/2018
2	Castration 05/2024 - 09/2022
2	Extracorporeal Shockwave Therapy 01/2023 - 01/2018
2	Aftercare (After-Treatment) 01/2023 - 10/2020
2	Nephrectomy 04/2021 - 01/2020
2	Transurethral Resection of Bladder 01/2020 - 01/2020
1	Salvage Therapy 01/2023
1	Local Anesthesia 09/2022
1	Drug Therapy (Chemotherapy) 06/2022